This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Clinicaltrials into cannabis’ potential as an opioid replacement are well underway in South Africa. According to the announcement, Biodata—a subsidiary of Labat Africa—“is the brainchild of Dr. The pilot results of the study were very promising, as it showed 98% of the patients have some sort of pain relief from cannabis.”.
of medical marijuana as a viable treatment option for certain conditions, including Multiple Sclerosis (MS), leading to increased advocacy for uniform regulations and broader accessibility. These improvements are particularly valuable for patients dealing with chronicpain and the psychological impact of a progressive disease.
House lawmakers introduced The Medical Cannabis Research Act of 2019 (HR 601), to facilitate federally-approved clinicaltrials involving cannabis. The measure would expand the pool of individuals eligible for medical cannabis by allowing physicians to recommend it to those with generalized chronicpain. CT resident?
Additionally, the advocacy group views Delta-8 THC as a Schedule I substance under federal law. A House subcommittee asked the Department of Veterans Affairs directors why they didn’t support a bipartisan bill ordering the department to conduct clinicaltrials on the potential benefits of medical marijuana. Law 360 (sub.
Veterans’ Access to Medical Marijuana The benefits of medical cannabis for veterans are many, but access to medical marijuana for veterans has been a topic of ongoing debate and advocacy. Veterans Outreach Programs: Several nonprofit organizations and advocacy groups specialize in assisting veterans with accessing medical marijuana.
Public discourse became more nuanced, with patients and advocacy groups championing the cause of medical marijuana as a legitimate and effective treatment option. Studies have shown the efficacy of medical cannabis in treating conditions such as chronicpain, epilepsy, and certain mental health disorders.
Chronicpain or pain were the conditions most frequently mentioned in articles about cannabis, followed by epilepsy, cancer or cancer pain, and nausea and chemotherapy. Pain and chronicpain were the most common conditions mentioned over the time period and were referred to in 62% of all articles.
However, social and economic barriers like racial stereotypes and lack of access to care centers have historically barred Hispanic community members from seeking medical cannabis and participating in clinicaltrials. Maha was the founder and president of UCLA’s first registered cannabis student group, Cannaclub.
Clinical research: Research is focusing on 5-MeO-DMT use in depression and anxiety. Current clinicaltrials are underway using a synthetic nasal spray of 5-MeO-DMT in patients with major depressive disorder. As such, there have been numerous clinicaltrials using ketamine.
The National Center for Biotechnology Information has summarized a group of FDA approved randomized clinicaltrials, finding evidence for cannabis as medicine. National Library of Medicine has more than 26,000 published studies/reviews across 24 databases regarding cannabis available to read online.
Because the categorization of a controlled substance determines its availability and accessibility, the benefits of rescheduling are important to patients suffering from chronicpain, epilepsy, and other conditions.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content